This February, Morris-Simon and her colleagues at Bayer are leveraging Heart Month and Black History Month as an opportunity to underscore Bayer’s commitment to heart health and to raise awareness ...
Observational data fill a knowledge gap in the absence of randomized trials comparing empagliflozin vs dapagliflozin in patients with type 2 diabetes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback